The Journal of Immunology, Vol 139, Issue 2 513-517, Copyright © 1987 by American Association of Immunologists

ARTICLES

Identification of interferon-gamma as the lymphokine that mediates leukotriene B4-induced immunoregulation

M Rola-Pleszczynski, L Bouvrette, D Gingras and M Girard

Leukotriene B4 (LTB4) has been shown to modulate lymphocyte responses in both a positive and a negative way, depending on the particular cell subsets it interacts with. Recent evidence also indicates that LTB4 can directly affect the production of cytokines such as interleukin 1 (IL 1) or interleukin 2 (IL 2) and interferon-gamma (IFN-gamma). In this report, we present evidence that human T cells pulsed with LTB4 modulate IL 1 production by human monocytes by secreting IFN-gamma. In fact, we found that LTB4-pulsed T cells were capable of inducing a suppression of lymphocyte proliferation if allowed to interact with monocytes, but that this suppression was reversed to an enhancing effect when monocytes were treated with the cyclooxygenase inhibitor indomethacin. Furthermore, LTB4-pulsed T cells released a soluble factor that would mediate both effects. This factor was found to be IFN- gamma, because affinity-purified IFN-gamma could reproduce the effects, and a rabbit polyclonal anti-serum to human IFN-gamma could block the activities of supernatants from LTB4-pulsed T cells. LTB4 was also shown to enhance IFN-gamma production by T4+ T cells and to inhibit IFN- gamma production by T8+ T cells. These results suggest that LTB4 may regulate immune cell functions by inducing IFN-gamma production by T4+ cells.

This article has been cited by other articles:

				A. Liu, H.-E. Claesson, Y. Mahshid, G. Klein, and E. Klein Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures Blood, March 1, 2008; 111(5): 2693 - 2703. [Abstract] [Full Text] [PDF]

				R Alten, E Gromnica-Ihle, C Pohl, J Emmerich, J Steffgen, R Roscher, R Sigmund, B Schmolke, and G Steinmann Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis Ann Rheum Dis, February 1, 2004; 63(2): 170 - 176. [Abstract] [Full Text] [PDF]

				J. L. Goulet, R. C. Griffiths, P. Ruiz, R. B. Mannon, P. Flannery, J. L. Platt, B. H. Koller, and T. M. Coffman Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice J. Immunol., December 1, 2001; 167(11): 6631 - 6636. [Abstract] [Full Text] [PDF]

				J. L. Goulet, R. C. Griffiths, P. Ruiz, R. F. Spurney, D. S. Pisetsky, B. H. Koller, and T. M. Coffman Deficiency of 5-Lipoxygenase Abolishes Sex-Related Survival Differences in MRL-lpr/lpr Mice J. Immunol., July 1, 1999; 163(1): 359 - 366. [Abstract] [Full Text] [PDF]

				C. Owman, A. Garzino-Demo, F. Cocchi, M. Popovic, A. Sabirsh, and R. C. Gallo The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells PNAS, August 4, 1998; 95(16): 9530 - 9534. [Abstract] [Full Text] [PDF]

				R. S. Byrum, J. L. Goulet, R. J. Griffiths, and B. H. Koller Role of the 5-Lipoxygenase-activating Protein (FLAP) in Murine Acute Inflammatory Responses J. Exp. Med., March 17, 1997; 185(6): 1065 - 1076. [Abstract] [Full Text] [PDF]